Compare OPXS & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OPXS | ORMP |
|---|---|---|
| Founded | 1987 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.0M | 104.6M |
| IPO Year | N/A | N/A |
| Metric | OPXS | ORMP |
|---|---|---|
| Price | $14.25 | $3.06 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 34.5K | ★ 272.5K |
| Earning Date | 12-17-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 23.32 | ★ 838.25 |
| EPS | 0.75 | ★ 1.03 |
| Revenue | ★ $39,481,000.00 | $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $20.35 | ★ $2.99 |
| Revenue Growth | ★ 21.00 | N/A |
| 52 Week Low | $5.36 | $1.82 |
| 52 Week High | $17.76 | $3.20 |
| Indicator | OPXS | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 47.55 | 74.94 |
| Support Level | $13.09 | $2.66 |
| Resistance Level | $15.44 | $3.20 |
| Average True Range (ATR) | 0.84 | 0.16 |
| MACD | 0.10 | 0.03 |
| Stochastic Oscillator | 47.31 | 83.47 |
Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, and light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Systems Richardson and Applied Optics Center Dallas and others. It generates maximum revenue from the Optex Systems Richardson segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor and others.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.